Lipid peroxidation and antioxidant status in experimental diabetes. 1999

C Feillet-Coudray, and E Rock, and C Coudray, and K Grzelkowska, and V Azais-Braesco, and D Dardevet, and A Mazur
Centre de Recherche en Nutrition Humaine d'Auvergne, Unité des Maladies Métaboliques et des Micronutriments, INRA, St. Genès Champanelle, France. feillet@clermont.inra.fr

Oxidative stress is currently suggested as a mechanism underlying diabetes. The present study was designed to evaluate the oxidative stress related parameters in streptozotocin-induced diabetes in rats using different complementary approaches: susceptibility to in vitro oxidation (lipid peroxidation induction in liver homogenate, red blood cells hemolysis), blood antioxidant status (total antioxidant capacity by two approaches), and plasma isoprostane measurement, a new marker of lipid peroxidation in vivo. We have shown that induced liver thiobarbituric acid reactive substances increased after 4 weeks of diabetes, in spite of increased liver vitamin E content. Red blood cells hemolysis was significantly delayed after 4 weeks of diabetes. Plasma antioxidant capacity (AOC) tended to increase after 4 weeks of diabetes and was correlated with plasma vitamin E levels. Total antioxidant activity (TAA) significantly decreased after 1 week and a significant correlation was observed with plasma albumin levels. Plasma isoprostane (8-epiprostaglandinF2alpha) concentrations were not modified significantly 1 week or 4 weeks after the induction of diabetes. Levels of vitamin E in the diet and changes in its distribution among the body seems to play an important role in the development of oxidative stress during diabetes and its consequences.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D013311 Streptozocin An antibiotic that is produced by Stretomyces achromogenes. It is used as an antineoplastic agent and to induce diabetes in experimental animals. Streptozotocin,2-Deoxy-2-((methylnitrosoamino)carbonyl)amino-D-glucose,Streptozotocine,Zanosar
D014280 Triglycerides An ester formed from GLYCEROL and three fatty acid groups. Triacylglycerol,Triacylglycerols,Triglyceride
D015227 Lipid Peroxidation Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor. Lipid Peroxidations,Peroxidation, Lipid,Peroxidations, Lipid
D015237 Dinoprost A naturally occurring prostaglandin that has oxytocic, luteolytic, and abortifacient activities. Due to its vasocontractile properties, the compound has a variety of other biological actions. PGF2,PGF2alpha,Prostaglandin F2,Prostaglandin F2alpha,9alpha,11beta-PGF2,Enzaprost F,Estrofan,PGF2 alpha,Prostaglandin F2 alpha,9alpha,11beta PGF2,F2 alpha, Prostaglandin,F2alpha, Prostaglandin,alpha, PGF2

Related Publications

C Feillet-Coudray, and E Rock, and C Coudray, and K Grzelkowska, and V Azais-Braesco, and D Dardevet, and A Mazur
September 2003, Cell biochemistry and function,
C Feillet-Coudray, and E Rock, and C Coudray, and K Grzelkowska, and V Azais-Braesco, and D Dardevet, and A Mazur
March 1997, Clinica chimica acta; international journal of clinical chemistry,
C Feillet-Coudray, and E Rock, and C Coudray, and K Grzelkowska, and V Azais-Braesco, and D Dardevet, and A Mazur
April 2000, Diabetes & metabolism,
C Feillet-Coudray, and E Rock, and C Coudray, and K Grzelkowska, and V Azais-Braesco, and D Dardevet, and A Mazur
January 2005, World journal of gastroenterology,
C Feillet-Coudray, and E Rock, and C Coudray, and K Grzelkowska, and V Azais-Braesco, and D Dardevet, and A Mazur
January 2008, Clinical and experimental obstetrics & gynecology,
C Feillet-Coudray, and E Rock, and C Coudray, and K Grzelkowska, and V Azais-Braesco, and D Dardevet, and A Mazur
March 1994, Free radical biology & medicine,
C Feillet-Coudray, and E Rock, and C Coudray, and K Grzelkowska, and V Azais-Braesco, and D Dardevet, and A Mazur
October 2001, Journal of toxicology and environmental health. Part A,
C Feillet-Coudray, and E Rock, and C Coudray, and K Grzelkowska, and V Azais-Braesco, and D Dardevet, and A Mazur
October 1997, The British journal of nutrition,
C Feillet-Coudray, and E Rock, and C Coudray, and K Grzelkowska, and V Azais-Braesco, and D Dardevet, and A Mazur
February 2006, Cancer investigation,
C Feillet-Coudray, and E Rock, and C Coudray, and K Grzelkowska, and V Azais-Braesco, and D Dardevet, and A Mazur
December 2000, Pediatric hematology and oncology,
Copied contents to your clipboard!